Publication details
Fixní kombinace v antiagregační léčbě
Title in English | Fixed-dose combinations of antiplatelet drugs |
---|---|
Authors | |
Year of publication | 2016 |
Type | Article in Periodical |
Magazine / Source | Kardiologická revue - Interní medicína |
MU Faculty or unit | |
Citation | |
Field | Cardiovascular diseases incl. cardiosurgery |
Keywords | antiplatelet therapy; fixed-dose combination; aspirin resistance; P2Y12 receptor blockers |
Description | Fixed-dose combinations of several active substances in one tablet provide advantages in the treatment of diabetes, hypertension and chronic pain. This issue is much more challenging when considering drug combinations that interfere with haemostasis. Indications of antiplatelet drugs vary depending on the duration of therapy required, the degree of aggressiveness of treatment and on the presence of numerous modifying factors influencing drug effectiveness. Combinations of these drugs increase the risk of major bleeding complications. Two fixed-dose antiplatelet pharmaceutical products are currently available: aspirin + dipyridamole and aspirin + clopidogrel. This article discusses the benefits and pitfalls of these combinations and provides an overview and comparison of other antiaggregation drugs and their potential for fi xed-dose preparations in the future. |